CELESTIAL — Celestial Biolabs Balance Sheet
0.000.00%
Consumer DefensivesMicro Cap
Annual balance sheet for Celestial Biolabs, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2015 March 31st | 2016 March 31st | 2017 March 31st | 2018 March 31st | 2019 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | — | — |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 8.45 | 9.18 | 4.11 | 0.099 | 0.504 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 97.9 | 134 | 89.3 | 214 | 164 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 461 | 487 | 178 | 310 | 226 |
Net Property, Plant And Equipment | 530 | 437 | 428 | 424 | 417 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 991 | 1,050 | 1,085 | 1,140 | 1,193 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 14.4 | 16.9 | 13.5 | 22.6 | 78.4 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 125 | 94.8 | 97 | 117 | 171 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 866 | 955 | 988 | 1,023 | 1,023 |
Total Liabilities & Shareholders' Equity | 991 | 1,050 | 1,085 | 1,140 | 1,193 |
Total Common Shares Outstanding |